Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.8899
-0.0101 (-1.12%)
At close: May 8, 2026, 4:00 PM EDT
0.8801
-0.0098 (-1.10%)
After-hours: May 8, 2026, 7:48 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 29 employees as of December 31, 2025. The number of employees increased by 1 or 3.57% compared to the previous year.
Employees
29
Change (1Y)
1
Growth (1Y)
3.57%
Revenue / Employee
n/a
Profits / Employee
-$991,690
Market Cap
103.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 1 | 3.57% |
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| aTyr Pharma | 60 |
| Vivani Medical | 42 |
| Cue Biopharma | 29 |
| NeurAxis | 24 |
| Cognition Therapeutics | 14 |
| Aldeyra Therapeutics | 8 |
ONCY News
- 5 days ago - Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer - GlobeNewsWire
- 12 days ago - Oncolytics says in alignment with FDA following pelareorep Type C meeting - TheFly
- 12 days ago - Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study - GlobeNewsWire
- 4 weeks ago - Oncolytics price target lowered to $5 from $7 at Lake Street - TheFly
- 4 weeks ago - Oncolytics schedules FDA meeting for pelareorep registrational path - TheFly
- 4 weeks ago - Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer - GlobeNewsWire
- 5 weeks ago - Oncolytics completes domicile change to the U.S. - TheFly
- 5 weeks ago - Oncolytics Biotech® Completes Domicile Change to the United States - GlobeNewsWire